Wortmannin, an inhibitor of PI3K, and genistein, a phytoestrogen down-regulating tyrosine kinase, have been used in cancer research demonstrating inhibition of cancer motility and EGFR signaling inhibition, respectively [38], [39]. This evidence concerns the gene EGFR and cancer.